Himanshu H. Shah is the Founder, President, and CIO of Shah Capital, which manages over $600 million in assets. He has more than 30 years of experience in global capital markets and entrepreneurial business acumen. Over the years, he has successfully advised many portfolio companies on both pragmatic strategy and disciplined execution.

Shah Capital is one of the largest shareholders of Emeren, a global solar power projects developer; Novavax, the covid vaccine maker; VEON, one of the largest emerging market telecom and digital operator; Yuchai, Asia’s largest diesel engine manufacturer in terms of units produced.

Shah Capital is also a leading investor in Marius Pharmaceuticals, which developed Kyzatrex, an FDA-approved drug for testosterone deficiency.